Silencing of circ_0000205 mitigates interleukin-1β-induced apoptosis and extracellular matrix degradation in chondrocytes via targeting miR-766-3p/ADAMTS5 axis.


Journal

Innate immunity
ISSN: 1753-4267
Titre abrégé: Innate Immun
Pays: United States
ID NLM: 101469670

Informations de publication

Date de publication:
02 2022
Historique:
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 3 5 2022
Statut: ppublish

Résumé

The aim of this study was to explore the role of hsa_circRNA_0000205 (circ_0000205) in chondrocyte injury in osteoarthritis (OA) and the underlying mechanism. Expression of circ_0000205, microRNA (miR)-766-3p and a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS)-5 was detected by quantitative real time (qRT)-polymerase chain reaction (PCR) and Western blot assays. Cell proliferation, apoptosis, and extracellular matrix (ECM) synthesis were examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and 5-ethynyl-2-deoxyuridine assays, flow cytometry, and qRT-PCR and Western blot assays. The target relationship between miR-766-3p and circ_0000205 or ADAMTS5 was confirmed by luciferase reporter assay and RNA immunoprecipitation. IL-1β treatment could attenuate cell viability of primary chondrocytes and proliferating cell nuclear antigen (PCNA) and collagen II type alpha-1 (COL2A1) levels, and elevate apoptosis rate and cleaved caspase-3, ADAMTS5 and matrix metalloproteinase-13 (MMP13) levels, suggesting that IL-1β induced chondrocyte apoptosis and ECM degradation. Expression of circ_0000205 was up-regulated in OA tissues and IL-1β-induced primary chondrocytes, accompanied with miR-766-3p down-regulation and ADAMTS5 up-regulation. Knockdown of circ_0000205 could mitigate IL-1β-induced above effects and improve cell proliferation. Moreover, both depleting miR-766-3p and promoting ADAMTS5 could partially counteract circ_0000205 knockdown roles in IL-1β-cultured primary chondrocytes. Notably, circ_0000205 was verified as a sponge for miR-766-3p via targeting, and ADAMTS5 was a direct target for miR-766-3p. Silencing circ_0000205 could protect chondrocytes from IL-1β-induced proliferation reduction, apoptosis, and ECM degradation by targeting miR-766-3p/ADAMTS5 axis.

Identifiants

pubmed: 35484121
doi: 10.1177/17534259221077078
pmc: PMC9058376
doi:

Substances chimiques

Interleukin-1beta 0
MIRN766 microRNA, human 0
MicroRNAs 0
RNA, Circular 0
ADAMTS5 Protein EC 3.4.24.-
ADAMTS5 protein, human EC 3.4.24.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-90

Références

Int J Genomics. 2017;2017:1746426
pubmed: 28758108
Curr Opin Clin Nutr Metab Care. 2003 May;6(3):289-93
pubmed: 12690261
Arthritis Rheumatol. 2014 Apr;66(4):969-78
pubmed: 24757148
Yonsei Med J. 2018 May;59(3):349-355
pubmed: 29611396
J Cell Biochem. 2018 Mar;119(3):2579-2587
pubmed: 28980719
J Biotechnol. 2016 Nov 20;238:42-51
pubmed: 27671698
Clin Orthop Relat Res. 2016 Aug;474(8):1886-93
pubmed: 26872913
Cell Physiol Biochem. 2017;44(1):38-52
pubmed: 29241192
Int J Exp Pathol. 2020 Feb;101(1-2):4-20
pubmed: 32219922
Nature. 2005 Mar 31;434(7033):648-52
pubmed: 15800625
Arthritis Rheum. 2012 Jun;64(6):1909-19
pubmed: 22143896
Cell Signal. 2019 Jan;53:212-223
pubmed: 30312659
Matrix Biol. 2018 Oct;71-72:225-239
pubmed: 29885460
Prim Care. 2013 Dec;40(4):821-36, vii
pubmed: 24209720
Int J Mol Med. 2019 Aug;44(2):630-642
pubmed: 31198977
Osteoarthritis Cartilage. 2015 Aug;23(8):1254-66
pubmed: 25800415
Biotechnol Lett. 2021 Apr;43(4):791-802
pubmed: 33404903
Biosci Rep. 2018 Oct 31;38(5):
pubmed: 30279209
Clin Orthop Surg. 2010 Mar;2(1):1-7
pubmed: 20190994
Theranostics. 2021 Jan 1;11(4):1877-1900
pubmed: 33408787
Aging (Albany NY). 2020 Oct 25;12(20):20163-20183
pubmed: 33099538
Eur Cell Mater. 2006 Oct 26;12:49-56; discussion 56
pubmed: 17068722
Wiley Interdiscip Rev RNA. 2020 Jul;11(4):e1584
pubmed: 31925936
Bone Joint Res. 2019 Aug 02;8(7):290-303
pubmed: 31463037
J Mol Med (Berl). 2016 Jul;94(7):771-85
pubmed: 27067395
J Cell Mol Med. 2021 Jan;25(1):120-131
pubmed: 33205602
Onco Targets Ther. 2017 May 05;10:2461-2471
pubmed: 28503069
Front Cell Dev Biol. 2020 Oct 07;8:594135
pubmed: 33117820
N Engl J Med. 2010 Oct 14;363(16):1521-31
pubmed: 20942668
Biochem J. 2016 Jan 1;473(1):e1-4
pubmed: 26657033
J Biol Chem. 2002 Jun 21;277(25):22201-8
pubmed: 11956193
Drug Des Devel Ther. 2020 Jul 07;14:2645-2655
pubmed: 32753846
Nature. 2005 Mar 31;434(7033):644-8
pubmed: 15800624
Arthritis Rheum. 2012 Jun;64(6):1697-707
pubmed: 22392533
Osteoarthritis Cartilage. 2008 Nov;16(11):1413-20
pubmed: 18485748
Mol Ther Nucleic Acids. 2021 May 08;24:856-867
pubmed: 34026329
Clin Geriatr Med. 2010 Aug;26(3):371-86
pubmed: 20699160

Auteurs

Guowen Li (G)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Heyuan Luo (H)

Department of Trauma Surgery, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Zhiyong Ding (Z)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Haofeng Liang (H)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Zhoupeng Lai (Z)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Shuzhen Chen (S)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Yuliang Huang (Y)

Department of Orthopedics, Huizhou Central People's Hospital, Huizhou, Guangdong Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH